A BILL 
To amend title XVIII of the Social Security Act to provide 
for a cap on beneficiary liability under part D of the 
Medicare program, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Capping Drug Costs 
4
for Seniors Act of 2021’’. 
5
01:38 Jul 27, 2021
H4417
2 
•HR 4417 IH
SEC. 2. MEDICARE PART D BENEFIT REDESIGN. 
1
(a) 
BENEFIT
STRUCTURE
REDESIGN.—Section 
2
1860D–2(b) of the Social Security Act (42 U.S.C. 1395w– 
3
102(b)) is amended— 
4
(1) in paragraph (2)— 
5
(A) in subparagraph (A), in the matter 
6
preceding clause (i), by inserting ‘‘for a year 
7
preceding 2022 and for costs above the annual 
8
deductible specified in paragraph (1) and up to 
9
the annual out-of-pocket threshold specified in 
10
paragraph (4)(B) for 2022 and each subsequent 
11
year’’ after ‘‘paragraph (3)’’; 
12
(B) in subparagraph (C)— 
13
(i) in clause (i), in the matter pre-
14
ceding subclause (I), by inserting ‘‘for a 
15
year preceding 2022,’’ after ‘‘paragraph 
16
(4),’’; and 
17
(ii) in clause (ii)(III), by striking 
18
‘‘and each subsequent year’’ and inserting 
19
‘‘and 2021’’; and 
20
(C) in subparagraph (D)— 
21
(i) in clause (i)— 
22
(I) in the matter preceding sub-
23
clause (I), by inserting ‘‘for a year 
24
preceding 2022,’’ after ‘‘paragraph 
25
(4),’’; and 
26
01:38 Jul 27, 2021
H4417
3 
•HR 4417 IH
(II) in subclause (I)(bb), by 
1
striking ‘‘a year after 2018’’ and in-
2
serting ‘‘each of years 2018 through 
3
2021’’; and 
4
(ii) in clause (ii)(V), by striking 
5
‘‘2019 and each subsequent year’’ and in-
6
serting ‘‘each of years 2019 through 
7
2021’’; 
8
(2) in paragraph (3)(A)— 
9
(A) in the matter preceding clause (i), by 
10
inserting ‘‘for a year preceding 2022,’’ after 
11
‘‘and (4),’’; and 
12
(B) in clause (ii), by striking ‘‘for a subse-
13
quent year’’ and inserting ‘‘for each of years 
14
2007 through 2021’’; and 
15
(3) in paragraph (4)— 
16
(A) in subparagraph (A)— 
17
(i) in clause (i)— 
18
(I) by redesignating subclauses 
19
(I) and (II) as items (aa) and (bb), 
20
respectively, and moving the margin 
21
of each such redesignated item 2 ems 
22
to the right; 
23
(II) in the matter preceding item 
24
(aa), as redesignated by subclause (I), 
25
01:38 Jul 27, 2021
H4417
4 
•HR 4417 IH
by striking ‘‘is equal to the greater 
1
of—’’ and inserting ‘‘is equal to— 
2
‘‘(I) for a year preceding 2022, 
3
the greater of—’’; 
4
(III) by striking the period at the 
5
end of item (bb), as redesignated by 
6
subclause (I), and inserting ‘‘; and’’; 
7
and 
8
(IV) by adding at the end the fol-
9
lowing: 
10
‘‘(II) for 2022 and each suc-
11
ceeding year, $0.’’; and 
12
(ii) in clause (ii)— 
13
(I) by striking ‘‘clause (i)(I)’’ and 
14
inserting ‘‘clause (i)(I)(aa)’’; and 
15
(II) by adding at the end the fol-
16
lowing new sentence: ‘‘The Secretary 
17
shall continue to calculate the dollar 
18
amounts specified in clause (i)(I)(aa), 
19
including with the adjustment under 
20
this clause, after 2021 for purposes of 
21
section 1860D–14(a)(1)(D)(iii).’’; 
22
(B) in subparagraph (B)— 
23
(i) in clause (i)— 
24
01:38 Jul 27, 2021
H4417
5 
•HR 4417 IH
(I) in subclause (V), by striking 
1
‘‘or’’ at the end; 
2
(II) in subclause (VI)— 
3
(aa) by striking ‘‘for a sub-
4
sequent year’’ and inserting ‘‘for 
5
2021’’; and 
6
(bb) by striking the period 
7
at the end and inserting a semi-
8
colon; and 
9
(III) by adding at the end the 
10
following new subclauses: 
11
‘‘(VII) for 2022, is equal to 
12
$2,000; or 
13
‘‘(VIII) for a subsequent year, is 
14
equal to the amount specified in this 
15
subparagraph for the previous year, 
16
increased by the annual percentage in-
17
crease described in paragraph (6) for 
18
the year involved.’’; and 
19
(ii) in clause (ii), by striking ‘‘clause 
20
(i)(II)’’ and inserting ‘‘clause (i)’’; 
21
(C) in subparagraph (C)(i), by striking 
22
‘‘and for amounts’’ and inserting ‘‘and, for a 
23
year preceding 2022, for amounts’’; and 
24
01:38 Jul 27, 2021
H4417
6 
•HR 4417 IH
(D) in subparagraph (E), by striking ‘‘In 
1
applying’’ and inserting ‘‘For each of years 
2
2011 through 2021, in applying’’. 
3
(b) 
DECREASING
REINSURANCE
PAYMENT 
4
AMOUNT.—Section 1860D–15(b)(1) of the Social Security 
5
Act (42 U.S.C. 1395w–115(b)(1)) is amended by inserting 
6
after ‘‘80 percent’’ the following: ‘‘(or, with respect to a 
7
coverage year after 2021, 20 percent)’’. 
8
(c) MANUFACTURER DISCOUNT PROGRAM.— 
9
(1) IN GENERAL.—Part D of title XVIII of the 
10
Social Security Act (42 U.S.C. 1395w–101 et seq.) 
11
is amended by inserting after section 1860D–14A 
12
the following new section: 
13
‘‘SEC. 1860D–14B. MANUFACTURER DISCOUNT PROGRAM. 
14
‘‘(a) ESTABLISHMENT.—The Secretary shall estab-
15
lish a manufacturer discount program (in this section re-
16
ferred to as the ‘program’). Under the program, the Sec-
17
retary shall enter into agreements described in subsection 
18
(b) with manufacturers and provide for the performance 
19
of the duties described in subsection (c). The Secretary 
20
shall establish a model agreement for use under the pro-
21
gram by not later than July 1, 2021, in consultation with 
22
manufacturers, and allow for comment on such model 
23
agreement. 
24
‘‘(b) TERMS OF AGREEMENT.— 
25
01:38 Jul 27, 2021
H4417
7 
•HR 4417 IH
‘‘(1) IN GENERAL.— 
1
‘‘(A) AGREEMENT.—An agreement under 
2
this section shall require the manufacturer to 
3
provide applicable beneficiaries access to dis-
4
counted prices for applicable drugs of the man-
5
ufacturer that are dispensed on or after Janu-
6
ary 1, 2022. 
7
‘‘(B) PROVISION OF DISCOUNTED PRICES 
8
AT THE POINT-OF-SALE.—The discounted prices 
9
described in subparagraph (A) shall be provided 
10
to the applicable beneficiary at the pharmacy or 
11
by the mail order service at the point-of-sale of 
12
an applicable drug. 
13
‘‘(C) TIMING OF AGREEMENT.— 
14
‘‘(i) SPECIAL
RULE
FOR
2022.—In 
15
order for an agreement with a manufac-
16
turer to be in effect under this section with 
17
respect to the period beginning on January 
18
1, 2022, and ending on December 31, 
19
2022, the manufacturer shall enter into 
20
such agreement not later than 30 days 
21
after the date of the establishment of a 
22
model agreement under subsection (a). 
23
‘‘(ii) 
2023 
AND
SUBSEQUENT 
24
YEARS.—In order for an agreement with a 
25
01:38 Jul 27, 2021
H4417
8 
•HR 4417 IH
manufacturer to be in effect under this 
1
section with respect to plan year 2023 or 
2
a subsequent plan year, the manufacturer 
3
shall enter into such agreement (or such 
4
agreement shall be renewed under para-
5
graph (4)(A)) not later than January 30 of 
6
the preceding year. 
7
‘‘(2) PROVISION OF APPROPRIATE DATA.—Each 
8
manufacturer with an agreement in effect under this 
9
section shall collect and have available appropriate 
10
data, as determined by the Secretary, to ensure that 
11
it can demonstrate to the Secretary compliance with 
12
the requirements under the program. 
13
‘‘(3) COMPLIANCE
WITH
REQUIREMENTS
FOR 
14
ADMINISTRATION
OF
PROGRAM.—Each manufac-
15
turer with an agreement in effect under this section 
16
shall comply with requirements imposed by the Sec-
17
retary or a third party with a contract under sub-
18
section (d)(3), as applicable, for purposes of admin-
19
istering the program, including any determination 
20
under subparagraph (A) of subsection (c)(1) or pro-
21
cedures established under such subsection (c)(1). 
22
‘‘(4) LENGTH OF AGREEMENT.— 
23
‘‘(A) IN GENERAL.—An agreement under 
24
this section shall be effective for an initial pe-
25
01:38 Jul 27, 2021
H4417
9 
•HR 4417 IH
riod of not less than 12 months and shall be 
1
automatically renewed for a period of not less 
2
than 1 year unless terminated under subpara-
3
graph (B). 
4
‘‘(B) TERMINATION.— 
5
‘‘(i) BY THE SECRETARY.—The Sec-
6
retary may provide for termination of an 
7
agreement under this section for a knowing 
8
and willful violation of the requirements of 
9
the agreement or other good cause shown. 
10
Such termination shall not be effective ear-
11
lier than 30 days after the date of notice 
12
to the manufacturer of such termination. 
13
The Secretary shall provide, upon request, 
14
a manufacturer with a hearing concerning 
15
such a termination, and such hearing shall 
16
take place prior to the effective date of the 
17
termination with sufficient time for such 
18
effective date to be repealed if the Sec-
19
retary determines appropriate. 
20
‘‘(ii) BY A MANUFACTURER.—A man-
21
ufacturer may terminate an agreement 
22
under this section for any reason. Any 
23
such termination shall be effective, with re-
24
spect to a plan year— 
25
01:38 Jul 27, 2021
H4417
10 
•HR 4417 IH
‘‘(I) if the termination occurs be-
1
fore January 30 of a plan year, as of 
2
the day after the end of the plan year; 
3
and 
4
‘‘(II) if the termination occurs on 
5
or after January 30 of a plan year, as 
6
of the day after the end of the suc-
7
ceeding plan year. 
8
‘‘(iii) EFFECTIVENESS
OF
TERMI-
9
NATION.—Any termination under this sub-
10
paragraph shall not affect discounts for 
11
applicable drugs of the manufacturer that 
12
are due under the agreement before the ef-
13
fective date of its termination. 
14
‘‘(iv) NOTICE TO THIRD PARTY.—The 
15
Secretary shall provide notice of such ter-
16
mination to a third party with a contract 
17
under subsection (d)(3) within not less 
18
than 30 days before the effective date of 
19
such termination. 
20
‘‘(c) DUTIES DESCRIBED.—The duties described in 
21
this subsection are the following: 
22
‘‘(1) ADMINISTRATION OF PROGRAM.—Admin-
23
istering the program, including— 
24
01:38 Jul 27, 2021
H4417
11 
•HR 4417 IH
‘‘(A) the determination of the amount of 
1
the discounted price of an applicable drug of a 
2
manufacturer; 
3
‘‘(B) the establishment of procedures 
4
under which discounted prices are provided to 
5
applicable beneficiaries at pharmacies or by 
6
mail order service at the point-of-sale of an ap-
7
plicable drug; 
8
‘‘(C) the establishment of procedures to 
9
ensure that, not later than the applicable num-
10
ber of calendar days after the dispensing of an 
11
applicable drug by a pharmacy or mail order 
12
service, the pharmacy or mail order service is 
13
reimbursed for an amount equal to the dif-
14
ference between— 
15
‘‘(i) the negotiated price of the appli-
16
cable drug; and 
17
‘‘(ii) the discounted price of the appli-
18
cable drug; 
19
‘‘(D) the establishment of procedures to 
20
ensure that the discounted price for an applica-
21
ble drug under this section is applied before any 
22
coverage or financial assistance under other 
23
health benefit plans or programs that provide 
24
coverage or financial assistance for the pur-
25
01:38 Jul 27, 2021
H4417
12 
•HR 4417 IH
chase or provision of prescription drug coverage 
1
on behalf of applicable beneficiaries as the Sec-
2
retary may specify; and 
3
‘‘(E) providing a reasonable dispute resolu-
4
tion mechanism to resolve disagreements be-
5
tween manufacturers, applicable beneficiaries, 
6
and the third party with a contract under sub-
7
section (d)(3). 
8
‘‘(2) MONITORING COMPLIANCE.— 
9
‘‘(A) IN
GENERAL.—The Secretary shall 
10
monitor compliance by a manufacturer with the 
11
terms of an agreement under this section. 
12
‘‘(B) NOTIFICATION.—If a third party 
13
with a contract under subsection (d)(3) deter-
14
mines that the manufacturer is not in compli-
15
ance with such agreement, the third party shall 
16
notify the Secretary of such noncompliance for 
17
appropriate enforcement under subsection (e). 
18
‘‘(3) COLLECTION OF DATA FROM PRESCRIP-
19
TION DRUG PLANS AND MA–PD PLANS.—The Sec-
20
retary may collect appropriate data from prescrip-
21
tion drug plans and MA–PD plans in a timeframe 
22
that allows for discounted prices to be provided for 
23
applicable drugs under this section. 
24
‘‘(d) ADMINISTRATION.— 
25
01:38 Jul 27, 2021
H4417
13 
•HR 4417 IH
‘‘(1) IN GENERAL.—Subject to paragraph (2), 
1
the Secretary shall provide for the implementation of 
2
this section, including the performance of the duties 
3
described in subsection (c). 
4
‘‘(2) LIMITATION.—In providing for the imple-
5
mentation of this section, the Secretary shall not re-
6
ceive or distribute any funds of a manufacturer 
7
under the program. 
8
‘‘(3) CONTRACT
WITH
THIRD
PARTIES.—The 
9
Secretary shall enter into a contract with one or 
10
more third parties to administer the requirements 
11
established by the Secretary in order to carry out 
12
this section. At a minimum, the contract with a 
13
third party under the preceding sentence shall re-
14
quire that the third party— 
15
‘‘(A) receive and transmit information be-
16
tween the Secretary, manufacturers, and other 
17
individuals or entities the Secretary determines 
18
appropriate; 
19
‘‘(B) receive, distribute, or facilitate the 
20
distribution of funds of manufacturers to ap-
21
propriate individuals or entities in order to 
22
meet the obligations of manufacturers under 
23
agreements under this section; 
24
01:38 Jul 27, 2021
H4417
14 
•HR 4417 IH
‘‘(C) provide adequate and timely informa-
1
tion to manufacturers, consistent with the 
2
agreement with the manufacturer under this 
3
section, as necessary for the manufacturer to 
4
fulfill its obligations under this section; and 
5
‘‘(D) permit manufacturers to conduct 
6
periodic audits, directly or through contracts, of 
7
the data and information used by the third 
8
party to determine discounts for applicable 
9
drugs of the manufacturer under the program. 
10
‘‘(4) 
PERFORMANCE
REQUIREMENTS.—The 
11
Secretary shall establish performance requirements 
12
for a third party with a contract under paragraph 
13
(3) and safeguards to protect the independence and 
14
integrity of the activities carried out by the third 
15
party under the program under this section. 
16
‘‘(5) IMPLEMENTATION.—The Secretary may 
17
implement the program under this section by pro-
18
gram instruction or otherwise. 
19
‘‘(6) ADMINISTRATION.—Chapter 35 of title 44, 
20
United States Code, shall not apply to the program 
21
under this section. 
22
‘‘(e) ENFORCEMENT.— 
23
01:38 Jul 27, 2021
H4417
15 
•HR 4417 IH
‘‘(1) AUDITS.—Each manufacturer with an 
1
agreement in effect under this section shall be sub-
2
ject to periodic audit by the Secretary. 
3
‘‘(2) CIVIL MONEY PENALTY.— 
4
‘‘(A) IN
GENERAL.—The Secretary may 
5
impose a civil money penalty on a manufacturer 
6
that fails to provide applicable beneficiaries dis-
7
counts for applicable drugs of the manufacturer 
8
in accordance with such agreement for each 
9
such failure in an amount the Secretary deter-
10
mines is commensurate with the sum of— 
11
‘‘(i) the amount that the manufac-
12
turer would have paid with respect to such 
13
discounts under the agreement, which will 
14
then be used to pay the discounts which 
15
the manufacturer had failed to provide; 
16
and 
17
‘‘(ii) 25 percent of such amount. 
18
‘‘(B) APPLICATION.—The provisions of 
19
section 1128A (other than subsections (a) and 
20
(b)) shall apply to a civil money penalty under 
21
this paragraph in the same manner as such 
22
provisions apply to a penalty or proceeding 
23
under section 1128A(a). 
24
01:38 Jul 27, 2021
H4417
16 
•HR 4417 IH
‘‘(f) CLARIFICATION REGARDING AVAILABILITY OF 
1
OTHER COVERED PART D DRUGS.—Nothing in this sec-
2
tion shall prevent an applicable beneficiary from pur-
3
chasing a covered part D drug that is not an applicable 
4
drug (including a generic drug or a drug that is not on 
5
the formulary of the prescription drug plan or MA–PD 
6
plan that the applicable beneficiary is enrolled in). 
7
‘‘(g) DEFINITIONS.—In this section: 
8
‘‘(1) APPLICABLE
BENEFICIARY.—The term 
9
‘applicable beneficiary’ means an individual who, on 
10
the date of dispensing a covered part D drug— 
11
‘‘(A) is enrolled in a prescription drug plan 
12
or an MA–PD plan; 
13
‘‘(B) is not enrolled in a qualified retiree 
14
prescription drug plan; and 
15
‘‘(C) has incurred costs for covered part D 
16
drugs in the year that are equal to or exceed 
17
the annual deductible specified in section 
18
1860D–2(b)(1) for such year. 
19
‘‘(2) APPLICABLE DRUG.—The term ‘applicable 
20
drug’, with respect to an applicable beneficiary 
21
means a covered part D drug— 
22
‘‘(A) approved under a new drug applica-
23
tion under section 505(b) of the Federal Food, 
24
Drug, and Cosmetic Act or, in the case of a bio-
25
01:38 Jul 27, 2021
H4417
17 
•HR 4417 IH
logic product, licensed under section 351 of the 
1
Public Health Service Act; and 
2
‘‘(B)(i) if the PDP sponsor of the prescrip-
3
tion drug plan or the MA organization offering 
4
the MA–PD plan uses a formulary, which is on 
5
the formulary of the prescription drug plan or 
6
MA–PD plan that the applicable beneficiary is 
7
enrolled in; 
8
‘‘(ii) if the PDP sponsor of the prescrip-
9
tion drug plan or the MA organization offering 
10
the MA–PD plan does not use a formulary, for 
11
which benefits are available under the prescrip-
12
tion drug plan or MA–PD plan that the appli-
13
cable beneficiary is enrolled in; or 
14
‘‘(iii) is provided through an exception or 
15
appeal. 
16
‘‘(3) APPLICABLE
NUMBER
OF
CALENDAR 
17
DAYS.—The term ‘applicable number of calendar 
18
days’ means— 
19
‘‘(A) with respect to claims for reimburse-
20
ment submitted electronically, 14 days; and 
21
‘‘(B) with respect to claims for reimburse-
22
ment submitted otherwise, 30 days. 
23
‘‘(4) DISCOUNTED PRICE.— 
24
01:38 Jul 27, 2021
H4417
18 
•HR 4417 IH
‘‘(A) IN GENERAL.—The term ‘discounted 
1
price’ means, with respect to an applicable drug 
2
of a manufacturer furnished during a year to 
3
an applicable beneficiary— 
4
‘‘(i) who has not incurred costs for 
5
covered part D drugs in the year that are 
6
equal to or exceed the annual out-of-pocket 
7
threshold specified in section 1860D– 
8
2(b)(4)(B)(i) for the year, 90 percent of 
9
the negotiated price of such drug; and 
10
‘‘(ii) who has incurred such costs in 
11
the year that are equal to or exceed such 
12
threshold for the year, 70 percent of the 
13
negotiated price of such drug. 
14
‘‘(B) CLARIFICATION.—Nothing in this 
15
section shall be construed as affecting the re-
16
sponsibility of an applicable beneficiary for pay-
17
ment of a dispensing fee for an applicable drug. 
18
‘‘(C) 
SPECIAL
CASE
FOR
CERTAIN 
19
CLAIMS.— 
20
‘‘(i) 
CLAIMS
SPANNING
DEDUCT-
21
IBLE.—In the case where the entire 
22
amount of the negotiated price of an indi-
23
vidual claim for an applicable drug with re-
24
spect to an applicable beneficiary does not 
25
01:38 Jul 27, 2021
H4417
19 
•HR 4417 IH
fall at or above the annual deductible spec-
1
ified in section 1860D–2(b)(1) for the 
2
year, the manufacturer of the applicable 
3
drug shall provide the discounted price 
4
under this section on only the portion of 
5
the negotiated price of the applicable drug 
6
that falls at or above such annual deduct-
7
ible. 
8
‘‘(ii) CLAIMS SPANNING OUT-OF-POCK-
9
ET THRESHOLD.—In the case where the 
10
entire amount of the negotiated price of an 
11
individual claim for an applicable drug 
12
with respect to an applicable beneficiary 
13
does not fall entirely below or entirely 
14
above the annual out-of-pocket threshold 
15
specified in section 1860D–2(b)(4)(B)(i) 
16
for the year, the manufacturer of the ap-
17
plicable drug shall provide the discounted 
18
price— 
19
‘‘(I) in accordance with subpara-
20
graph (A)(i) on the portion of the ne-
21
gotiated price of the applicable drug 
22
that falls below such threshold; and 
23
‘‘(II) in accordance with subpara-
24
graph (A)(ii) on the portion of such 
25
01:38 Jul 27, 2021
H4417
20 
•HR 4417 IH
price of such drug that falls at or 
1
above such threshold. 
2
‘‘(5) MANUFACTURER.—The term ‘manufac-
3
turer’ means any entity which is engaged in the pro-
4
duction, preparation, propagation, compounding, 
5
conversion, or processing of prescription drug prod-
6
ucts, either directly or indirectly by extraction from 
7
substances of natural origin, or independently by 
8
means of chemical synthesis, or by a combination of 
9
extraction and chemical synthesis. Such term does 
10
not include a wholesale distributor of drugs or a re-
11
tail pharmacy licensed under State law. 
12
‘‘(6) NEGOTIATED
PRICE.—The term ‘nego-
13
tiated price’ has the meaning given such term in sec-
14
tion 423.100 of title 42, Code of Federal Regula-
15
tions (as in effect on the date of enactment of sec-
16
tion 1860D–14A), except that such negotiated price 
17
shall not include any dispensing fee for the applica-
18
ble drug. 
19
‘‘(7) QUALIFIED RETIREE PRESCRIPTION DRUG 
20
PLAN.—The term ‘qualified retiree prescription drug 
21
plan’ has the meaning given such term in section 
22
1860D–22(a)(2).’’. 
23
(2) SUNSET OF MEDICARE COVERAGE GAP DIS-
24
COUNT PROGRAM.—Section 1860D–14A of the So-
25
01:38 Jul 27, 2021
H4417
21 
•HR 4417 IH
cial Security Act (42 U.S.C. 1395–114a) is amend-
1
ed— 
2
(A) in subsection (a), in the first sentence, 
3
by striking ‘‘The Secretary’’ and inserting 
4
‘‘Subject to subsection (h), the Secretary’’; and 
5
(B) by adding at the end the following new 
6
subsection: 
7
‘‘(h) SUNSET OF PROGRAM.— 
8
‘‘(1) IN
GENERAL.—The program shall not 
9
apply with respect to applicable drugs dispensed on 
10
or after January 1, 2022, and, subject to paragraph 
11
(2), agreements under this section shall be termi-
12
nated as of such date. 
13
‘‘(2) CONTINUED APPLICATION FOR APPLICA-
14
BLE
DRUGS
DISPENSED
PRIOR
TO
SUNSET.—The 
15
provisions of this section (including all responsibil-
16
ities and duties) shall continue to apply after Janu-
17
ary 1, 2022, with respect to applicable drugs dis-
18
pensed prior to such date.’’. 
19
(3) INCLUSION OF ACTUARIAL VALUE OF MANU-
20
FACTURER DISCOUNTS IN BIDS.—Section 1860D–11 
21
of the Social Security Act (42 U.S.C. 1395w–111) 
22
is amended— 
23
(A) in subsection (b)(2)(C)(iii)— 
24
01:38 Jul 27, 2021
H4417
22 
•HR 4417 IH
(i) by striking ‘‘assumptions regarding 
1
the reinsurance’’ an inserting ‘‘assump-
2
tions regarding— 
3
‘‘(I) the reinsurance’’; and 
4
(ii) by adding at the end the fol-
5
lowing: 
6
‘‘(II) for 2022 and each subse-
7
quent year, the manufacturer dis-
8
counts provided under section 1860D– 
9
14B subtracted from the actuarial 
10
value to produce such bid; and’’; and 
11
(B) in subsection (c)(1)(C)— 
12
(i) by striking ‘‘an actuarial valuation 
13
of the reinsurance’’ and inserting ‘‘an ac-
14
tuarial valuation of— 
15
‘‘(i) the reinsurance’’; 
16
(ii) in clause (i), as inserted by clause 
17
(i) of this subparagraph, by adding ‘‘and’’ 
18
at the end; and 
19
(iii) by adding at the end the fol-
20
lowing: 
21
‘‘(ii) for 2022 and each subsequent 
22
year, the manufacturer discounts provided 
23
under section 1860D–14B;’’. 
24
(d) CONFORMING AMENDMENTS.— 
25
01:38 Jul 27, 2021
H4417
23 
•HR 4417 IH
(1) Section 1860D–2 of the Social Security Act 
1
(42 U.S.C. 1395w–102) is amended— 
2
(A) in subsection (a)(2)(A)(i)(I), by strik-
3
ing ‘‘, or an increase in the initial’’ and insert-
4
ing ‘‘or, for a year preceding 2022, an increase 
5
in the initial’’; 
6
(B) in subsection (c)(1)(C)— 
7
(i) in the subparagraph heading, by 
8
striking ‘‘AT
INITIAL
COVERAGE
LIMIT’’; 
9
and 
10
(ii) by inserting ‘‘for a year preceding 
11
2022 or the annual out-of-pocket threshold 
12
specified in subsection (b)(4)(B) for the 
13
year for 2022 and each subsequent year’’ 
14
after ‘‘subsection (b)(3) for the year’’ each 
15
place it appears; and 
16
(C) in subsection (d)(1)(A), by striking ‘‘or 
17
an initial’’ and inserting ‘‘or, for a year pre-
18
ceding 2022, an initial’’. 
19
(2) Section 1860D–4(a)(4)(B)(i) of the Social 
20
Security Act (42 U.S.C. 1395w–104(a)(4)(B)) is 
21
amended by striking ‘‘the initial’’ and inserting ‘‘for 
22
a year preceding 2022, the initial’’. 
23
(3) Section 1860D–14(a) of the Social Security 
24
Act (42 U.S.C. 1395w–114(a)) is amended— 
25
01:38 Jul 27, 2021
H4417
24 
•HR 4417 IH
(A) in paragraph (1)— 
1
(i) in subparagraph (C), by striking 
2
‘‘The continuation’’ and inserting ‘‘For a 
3
year preceding 2022, the continuation’’; 
4
(ii) in subparagraph (D)(iii), by strik-
5
ing ‘‘1860D–2(b)(4)(A)(i)(I)’’ and insert-
6
ing ‘‘1860D–2(b)(4)(A)(i)(I)(aa)’’; and 
7
(iii) in subparagraph (E), by striking 
8
‘‘The elimination’’ and inserting ‘‘For a 
9
year preceding 2022, the elimination’’; and 
10
(B) in paragraph (2)— 
11
(i) in subparagraph (C), by striking 
12
‘‘The continuation’’ and inserting ‘‘For a 
13
year preceding 2022, the continuation’’; 
14
and 
15
(ii) in subparagraph (E)— 
16
(I) by inserting ‘‘for a year pre-
17
ceding 2022,’’ after ‘‘subsection (c)’’; 
18
and 
19
(II) 
by 
striking 
‘‘1860D– 
20
2(b)(4)(A)(i)(I)’’ 
and 
inserting 
21
‘‘1860D–2(b)(4)(A)(i)(I)(aa)’’. 
22
(4) Section 1860D–21(d)(7) of the Social Secu-
23
rity Act (42 U.S.C. 1395w–131(d)(7)) is amended 
24
01:38 Jul 27, 2021
H4417
25 
•HR 4417 IH
by striking ‘‘section 1860D–2(b)(4)(B)(i)’’ and in-
1
serting ‘‘section 1860D–2(b)(4)(C)(i)’’. 
2
(5) Section 1860D–22(a)(2)(A) of the Social 
3
Security Act (42 U.S.C. 1395w–132(a)(2)(A)) is 
4
amended— 
5
(A) by striking ‘‘the value of any discount’’ 
6
and inserting the following: ‘‘the value of— 
7
‘‘(i) for years prior to 2022, any dis-
8
count’’; 
9
(B) in clause (i), as inserted by subpara-
10
graph (A) of this paragraph, by striking the pe-
11
riod at the end and inserting ‘‘; and’’; and 
12
(C) by adding at the end the following new 
13
clause: 
14
‘‘(ii) for 2022 and each subsequent 
15
year, any discount provided pursuant to 
16
section 1860D–14B.’’. 
17
(6) Section 1860D–41(a)(6) of the Social Secu-
18
rity Act (42 U.S.C. 1395w–151(a)(6)) is amended— 
19
(A) by inserting ‘‘for a year before 2022’’ 
20
after ‘‘1860D–2(b)(3)’’; and 
21
(B) by inserting ‘‘for such year’’ before the 
22
period. 
23
01:38 Jul 27, 2021
H4417
26 
•HR 4417 IH
(7) Paragraph (1) of section 1860D–43(a) of 
1
the Social Security Act (42 U.S.C. 1395w–153(a)) is 
2
amended to read as follows: 
3
‘‘(1) participate in— 
4
‘‘(A) for 2011 through 2021, the Medicare 
5
coverage gap discount program under section 
6
1860D–14A; and 
7
‘‘(B) for 2022 and each subsequent year, 
8
the manufacturer discount program under sec-
9
tion 1860D–14B;’’. 
10
(e) EFFECTIVE DATE.—The amendments made by 
11
this section shall apply with respect to plan year 2022 and 
12
subsequent plan years. 
13
Æ 
01:38 Jul 27, 2021
H4417
